Clinigen Group plc provided unaudited trading update for the year ended 30 June 2018. Revenues increased by around 26% on a reported basis and by around 27% on a constant currency basis compared to last year.

The company provided earnings guidance for the year 2018. Following tight cost control and benefits obtained from the integration of the acquisitions, EBITDA growth is expected to increase at a higher rate than gross profit.